ESSEX BIO-TECH (01061.HK) purchased 0.033 million shares for 0.0899 million Hong Kong dollars on December 18.

Gelonghui reported on December 18 that ESSEX BIO-TECH (01061.HK) announced that on December 18, 2024, it spent 0.0899 million Hong Kong dollars to repurchase 0.033 million shares, with a repurchase price of 2.72-2.75 Hong Kong dollars per share.

Gelonghui Finance16:53

Stock buyback summary on December 17 | TENCENT, AIA and others have conducted buybacks, among which TENCENT spent 0.703 billion HKD.

According to a document disclosed by the HKEX on December 18, TENCENT (00700.HK), AIA (01299.HK), and others have repurchased shares. ① TENCENT (00700.HK) repurchased 1.74 million ordinary shares on December 17, involving an amount of 0.703 billion HKD, with a repurchase price ranging from 407 HKD to 401.8 HKD per share. Since the approval of the repurchase authorization resolution, the cumulative number of securities repurchased is 0.218 billion shares, accounting for 2.311% of the number of shares issued at the time of the ordinary resolution.

Futu News09:00

ESSEX BIO-TECH (01061.HK) repurchased 0.02 million shares on December 17.

Gelonghui reported on December 17 that ESSEX BIO-TECH (01061.HK) announced that on December 17, 2024, it spent 0.0552 million Hong Kong dollars to repurchase 0.02 million shares at a price of 2.76 Hong Kong dollars per share.

Gelonghui FinanceDec 17 17:00

Buyback collection on December 16 | TENCENT, HSBC Holdings, and others have made repurchases, with TENCENT spending 0.7 billion HKD.

According to documents disclosed by HKEX on December 17, TENCENT (00700.HK), HSBC Holdings (00005.HK), and others repurchased shares. ① TENCENT (00700.HK) repurchased 1.72 million ordinary shares on December 16, involving an amount of 0.7 billion Hong Kong dollars, with a repurchase price ranging from 410.8 Hong Kong dollars to 403.8 Hong Kong dollars per share. Since the authorization resolution for repurchase, the cumulative number of securities repurchased is 0.216 billion shares, accounting for 2.292% of the number of shares issued at the time the ordinary resolution was passed. ② HSBC Holdings (00005.HK) on December 12.

Futu NewsDec 17 09:20

ESSEX BIO-TECH (01061.HK) repurchased 0.03 million shares on December 16.

Gelonghui reported on December 16 that ESSEX BIO-TECH (01061.HK) announced it spent 0.0834 million HKD to repurchase 0.03 million shares on December 16, 2024, at a price of 2.78 HKD per share.

Gelonghui FinanceDec 16 17:17

Sinolink: The end of year centralized purchasing expectations are gradually being cleared, and the pharmaceutical sector行情 is expected to gradually start.

The pharmaceutical Sector is currently in a process of a triple reversal in performance, policies, and funding, with full confidence in the recovery of revenue profit growth and market resurgence of listed companies in the Sector by 2025.

Zhitong FinanceDec 16 14:21